Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare CancersPeter Horak, Klaus Schulze‐Osthoff, Arne Jahn et al.|Cancer Discovery|2021Cited by 282
Community-driven development of a modified progression-free survival ratio for precision oncologyAndreas Möck, Anna Lena Illert, Christoph E. Heilig et al.|ESMO Open|2019Cited by 44
Preinfection laboratory parameters may predict COVID‐19 severity in tumor patientsAlexander Kiani, Ralph Naumann, Romina Roesch et al.|Cancer Medicine|2021Cited by 6
1496P Trabectedin for patients with advanced soft tissue sarcoma: A non-interventional, prospective, multicenter studyViktor Grünwald, Philipp Ivanyi, Daniel Pink et al.|Annals of Oncology|2022Cited by 1